NEOG 250117 7.50C (NEOG250117C7500) Stock Options, News & Quotes

US OptionsDetailed Quotes

NEOG250117C7500

Watchlist

9.43
0.000.00%

15min DelayTrading Jan 17 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Neogen Introduces Igenity BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk
PR NewswireJan 21 08:45 ET
Piper Sandler Maintains Neogen(NEOG.US) With Hold Rating, Cuts Target Price to $13
Moomoo NewsJan 21 07:31 ET · Ratings
Piper Sandler Keeps Their Hold Rating on Neogen (NEOG)
TipRanksJan 21 06:48 ET · Ratings
Neogen Price Target Lowered to $13 From $16.50 at Piper Sandler
TipRanksJan 21 06:35 ET
Insider Purchase: CEO of $NEOG (NEOG) Buys 23,035 Shares
Quiver QuantitativeJan 16 12:15 ET
Anticoagulant Rodenticides Market Trends Analysis Report 2025-2030, Featuring BASF, Bayer, Syngenta, PelGar, Rentokil, UPL, Bell Labs, Kalyani Industries, Heranba Industries, Neogen and Liphatech
Yahoo FinanceJan 16 11:38 ET

Comments

Stock_Drift

Jan 10 06:15

$Neogen (NEOG.US)$

Stock_Drift

Sep 19, 2024 07:51

$Neogen (NEOG.US)$

Moomoo AI

Feb 23, 2024 04:37

Despite Neogen's profitability and revenue growth, its share price drop is surprising and needs further investigation. The company's future earnings are crucial for shareholders. The recent loss is less severe than the 8% annual loss over the last half decade. Clear growth indications are needed before assuming share price stability.

Neogen (NASDAQ:NEOG) Investors Are Sitting on a Loss of 58% If They Invested Three Years Ago

Moomoo AI

Nov 1, 2023 09:09

The drop in stock price is in line with the decline in Neogen's earnings, which is expected under normal market conditions. The recent insider buying may suggest some confidence in the company's future prospects despite the slump in financial performance.

Neogen (NASDAQ:NEOG) Investors Are Sitting on a Loss of 58% If They Invested Three Years Ago

Analysts Notebook

Jun 16, 2023 07:08

Columns US Top Rating Updates on 6/16: WST, AZO, RES, EVO and MORE

$MorphoSys (MOR.US)$initiated at overweight by Wells Fargo, announced target price at $17.00.
$Guess (GES.US)$initiated at neutral by UBS, announced targe price at $22.00.
$West Pharmaceutical Services (WST.US)$was upgraded by Bank of America Securities from neutral to buy, increased target price from $390.00 to $405.00.
$AutoZone (AZO.US)$was upgraded by UBS from neutral to buy, increased target price from $2800.00 to $2900.00.
$RPC Inc (RES.US)$was downgr...